The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug Patent
Keyword(s):
Keyword(s):
Keyword(s):
2010 ◽
Vol 103
(7)
◽
pp. 1008-1018
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 96
◽
pp. 107541
Keyword(s):